Construction and validation of a novel SUMOylation-related lncRNAs signature for predicting the prognosis, tumor immune microenvironment, and therapeutic sensitivity of lung adenocarcinoma

Jie Cai; Weizhong Ruan; Zida Wang; Gongzhe Liu; Bei Yang; Hao Wang; Deping Zhao; Chang Chen; Xiaogang Zhao

doi:10.1016/j.gendis.2024.101338

| Sign up

PDF (1 MB)

Cite

EndNote(RIS) BibTeX

Collect

Submit Manuscript

Show Outline

Outline

References

Show full outline

Hide outline

Rapid Communication | Open Access

Construction and validation of a novel SUMOylation-related lncRNAs signature for predicting the prognosis, tumor immune microenvironment, and therapeutic sensitivity of lung adenocarcinoma

Jie Cai^{^a^,¹}, Weizhong Ruan^{^b^,¹}, Zida Wang^{^c^,¹}, Gongzhe Liu^{^d}, Bei Yang^{^a}, Hao Wang^{^a}, Deping Zhao^{^a}(), Chang Chen^{^a}(), Xiaogang Zhao^{^a}()

Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China

Department of Thoracic Surgery, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital (Fujian Branch of Fudan University Shanghai Cancer Center), Fuzhou, Fujian 350014, China

Department of Emergency, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China

Department of Cardiothoracic Surgery, People’s Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 271199, China

¹ These authors have contributed equally to this work.

Peer review under responsibility of Chongqing Medical University.

Show Author Information

References

Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17-48.

Crossref Google Scholar

Chaft JE, Rimner A, Weder W, Azzoli CG, Kris MG, Cascone T. Evolution of systemic therapy for stages Ⅰ-Ⅲ non-metastatic non-small-cell lung cancer. Nat Rev Clin Oncol. 2021;18(9):547-557.

Crossref Google Scholar

Xie M, Yu J, Ge S, Huang J, Fan X. SUMOylation homeostasis in tumorigenesis. Cancer Lett. 2020;469:301-309.

Google Scholar

Hu FF, Liu CJ, Liu LL, Zhang Q, Guo AY. Expression profile of immune checkpoint genes and their roles in predicting immunotherapy response. Briefings Bioinf. 2021;22(3):bbaa176.

Google Scholar

Chan TA, Yarchoan M, Jaffee E, et al. Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic. Ann Oncol. 2019;30(1):44-56.

Crossref Google Scholar

Genes & Diseases

Volume 12 Issue 2,
March 2025

Article number: 101338

DOI: 10.1016/j.gendis.2024.101338

Cite this article:

Cai J, Ruan W, Wang Z, et al. Construction and validation of a novel SUMOylation-related lncRNAs signature for predicting the prognosis, tumor immune microenvironment, and therapeutic sensitivity of lung adenocarcinoma. Genes & Diseases, 2025, 12(2): 101338. https://doi.org/10.1016/j.gendis.2024.101338